Rivolo S, Di Fusco M, Polanco C, Kang A, et al. Cost-effectiveness analysis of apixaban versus vitamin K antagonists for
antithrombotic therapy in patients with atrial fibrillation after acute coronary
syndrome or percutaneous coronary intervention in Spain. PLoS One 2021;16:e0259251.
PMID: 34767564